Organogenesis Holdings Inc. (ORGO)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$1.49
-2.94%
Mkt Cap $191.72M
Analyst Ratings
Buy
1
Hold
1
Sell
0
Price Target (6 analysts)
$2.50
Range $2.00 – $3.00
Implied Upside
+67.8%
Consensus $2.50 vs current $1.49